These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Topics in medicine: the urine of patients with bladder cancer]. Shibusawa K. Kango; 1983 Jan; 35(1):104. PubMed ID: 6551554 [No Abstract] [Full Text] [Related]
27. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma]. Fernández Gómez JM, García Rodríguez J, Escaf Barmadah S, Raigoso P, Rodríguez Martínez JJ, Allende MT, Casasola Chamorro J, Rodríguez Faba O, Martín Benito JL, Regadera Sejas FJ. Arch Esp Urol; 2002 Jan; 55(1):41-9. PubMed ID: 11957750 [Abstract] [Full Text] [Related]
29. Bladder cancer detection using FISH (UroVysion assay). Halling KC, Kipp BR. Adv Anat Pathol; 2008 Sep; 15(5):279-86. PubMed ID: 18724101 [Abstract] [Full Text] [Related]
30. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder. Rosen EM, Joseph A, Jin L, Yao Y, Chau MH, Fuchs A, Gomella L, Hastings H, Goldberg ID, Weiss GH. J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219 [Abstract] [Full Text] [Related]
32. The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine. Siracusano S, Niccolini B, Knez R, Tiberio A, Benedetti E, Bonin S, Ciciliato S, Pappagallo GL, Belgrano E, Stanta G. Eur Urol; 2005 Mar; 47(3):327-33. PubMed ID: 15716196 [Abstract] [Full Text] [Related]
33. Determination of diagnostic and prognostic values of urinary interleukin-8, tumor necrosis factor-alpha, and leukocyte arylsulfatase-A activity in patients with bladder cancer. Koçak H, Oner-Iyidoğan Y, Koçak T, Oner P. Clin Biochem; 2004 Aug; 37(8):673-8. PubMed ID: 15302609 [Abstract] [Full Text] [Related]
36. [Quantification of bladder tumor antigen (BTA trak) and its correlation with bladder cancer grade and stage]. Rodríguez Martínez JJ, Escaf Barmadah S, Allende MT, Raigoso P, Martín Benito JL, Pérez García FJ, Fernández Gómez JM. Arch Esp Urol; 2000 Aug; 53(1):1-6. PubMed ID: 10730418 [Abstract] [Full Text] [Related]
37. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer. Yu J, Zhu T, Wang Z, Zhang H, Qian Z, Xu H, Gao B, Wang W, Gu L, Meng J, Wang J, Feng X, Li Y, Yao X, Zhu J. Clin Cancer Res; 2007 Dec 15; 13(24):7296-304. PubMed ID: 18094410 [Abstract] [Full Text] [Related]
38. Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients. Okragly AJ, Niles AL, Saban R, Schmidt D, Hoffman RL, Warner TF, Moon TD, Uehling DT, Haak-Frendscho M. J Urol; 1999 Feb 15; 161(2):438-41; discussion 441-2. PubMed ID: 9915421 [Abstract] [Full Text] [Related]
39. Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology. Daniely M, Rona R, Kaplan T, Olsfanger S, Elboim L, Freiberger A, Lew S, Leibovitch I. Cancer; 2007 Dec 25; 111(6):517-24. PubMed ID: 17963263 [Abstract] [Full Text] [Related]